John Trowsdale, PhD
Chief Scientific Officer
Dr. Trowsdale oversees the overall research strategy in close collaboration with the company’s scientific advisors and inhouse team. Dr. Trowsdale is an Emeritus Professor of Immunology in the University of Cambridge UK. He has over 400 scientific publications. He was one of the first to clone MHC genes and to study their impact on susceptibility to infection, autoimmunity, and cancer, and subsequently identified components of antigen processing such as TAP transporters, the immunoproteasome and the tapasin-related TAPBPR molecule. He also headed a group developing novel, high-throughput methods for typing polymorphic receptors on Natural Killer Cells and uncovered their roles in regulating disease. Dr. Trowsdale completed his PhD in 1973 at the University of Birmingham, UK. He was a postdoctoral fellow at the CNRS in Paris and the Scripps Clinic in La Jolla. Before taking his professorship in Cambridge John was head of the Human Immunogenetics laboratory at Cancer Research UK in London.